Literature DB >> 19884538

Critical review of the determination process by the Japanese reviewing authority in approving the additional efficacy of fludarabine phosphate.

Hiroto Narimatsu, Giichiro Oiso, Shunsuke Ono, Masahiro Kami.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19884538     DOI: 10.1200/JCO.2009.23.9020

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Approving molecularly targeted drugs: different approval processes for cytotoxic agents.

Authors:  Yuriko Sasahara; Hiroto Narimatsu; Akira Fukao; Takashi Yoshioka
Journal:  Int J Clin Oncol       Date:  2016-04-22       Impact factor: 3.402

2.  Comprehensive analysis of clinical development and regulatory submission promotion schemes for oncologic drugs as the Japanese national projects.

Authors:  Sumimasa Nagai; Keiya Ozawa
Journal:  Invest New Drugs       Date:  2016-08-19       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.